Over the last 12 months, TransMedics Group insiders reported 1 buy totaling $109K and 10 sales totaling $4.7M across SEC Form 4 filings.
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Decision | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | TOBIN JAMES RD | ▼ Sale | Discretionaryopen market | 4,059 | $94.97 | $385K | -58.1% | 2 tranches |
| Sep 11, 2026 | Weill DavidD | ▲ Buy | — | 1,336 | $81.63 | $109K | +8.9% | — |
| Jun 15, 2026 | Gunderson Thomas J.D | ▼ Sale | Non-discretionarytax on vesting | 9,624 | $75.06 | $722K | -36.6% | — |
| Mar 4, 2026 | Lovell StephanieD | ▼ Sale | Discretionaryopen market | 1,193 | $149.62 | $178K | -29.4% | — |
| Mar 4, 2026 | Weill DavidD | ▼ Sale | Discretionaryexercise and sell | 3,571 | $146.82 | $524K | -22.7% | — |
| Mar 4, 2026 | Hernandez GerardoChief Financial Officer · O | ▼ Sale | Discretionaryopen market | 7,611 | $146.81 | $1.1M | -34.1% | 3 tranches |
| Mar 2, 2026 | Ranganath Anil P.See remarks · O | ▼ Sale | Non-discretionarytax on vesting | 864 | $139.12 | $120K | -6.2% | — |
| Mar 2, 2026 | Corcoran NicholasSee remarks · O | ▼ Sale | Non-discretionarytax on vesting | 2,966 | $139.12 | $413K | -9% | — |
| Dec 4, 2025 | Hernandez GerardoChief Financial Officer · O | ▼ Sale | Non-discretionarytax on vesting | 920 | $139.62 | $128K | -5.8% | — |
| Dec 3, 2025 | Weill DavidD | ▼ Sale | Discretionaryexercise and sell | 5,000 | $138.64 | $693K | -29.2% | — |
| Nov 25, 2025 | Ranganath Anil P.See remarks · O | ▼ Sale | Discretionaryexercise and sell | 3,000 | $145.22 | $436K | -17.7% | — |
| Nov 17, 2025 | Hassanein Waleed HPresident & CEO · O·D | ▲ Buy | — | 8,775 | $114 | $1.0M | +1.8% | indirect |
| Oct 29, 2025 | Basile Edward MD | ▼ Sale | Non-discretionary10b5-1 plan | 4,142 | $130.45 | $540K | -59.1% | — |
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? TransMedics Group filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $TMDX feed.